A new trading day began on Monday, with Mind Medicine Inc (NASDAQ: MNMD) stock price up 10.02% from the previous day of trading, before settling in for the closing price of $10.68. MNMD’s price has ranged from $4.70 to $14.43 over the past 52 weeks.
A company in the Healthcare sector has jumped its sales by 12.11% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged -31.17%. With a float of $73.33 million, this company’s outstanding shares have now reached $76.77 million.
Mind Medicine Inc (MNMD) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Mind Medicine Inc is 2.94%, while institutional ownership is 51.73%. The most recent insider transaction that took place on Sep 25 ’25, was worth 110,186. In this transaction Chief Legal Officer of this company sold 11,278 shares at a rate of $9.77, taking the stock ownership to the 293,852 shares. Before that another transaction happened on Sep 25 ’25, when Company’s Chief Executive Officer sold 25,797 for $9.77, making the entire transaction worth $252,037. This insider now owns 804,268 shares in total.
Mind Medicine Inc (MNMD) Latest Financial update
In its latest quarterly report, released on 12/31/2024, the company reported earnings of -0.41 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.45 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -31.17% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -3.63% during the next five years compared to 12.11% growth over the previous five years of trading.
Mind Medicine Inc (NASDAQ: MNMD) Trading Performance Indicators
Here are Mind Medicine Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.30.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.97, a number that is poised to hit -0.51 in the next quarter and is forecasted to reach -1.77 in one year’s time.
Technical Analysis of Mind Medicine Inc (MNMD)
Let’s dig in a bit further. During the last 5-days, its volume was 1.53 million. That was inferior than the volume of 1.59 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 19.49%.
During the past 100 days, Mind Medicine Inc’s (MNMD) raw stochastic average was set at 64.17%, which indicates a significant increase from 47.87% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.87 in the past 14 days, which was higher than the 0.69 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $11.75, while its 200-day Moving Average is $8.63. However, in the short run, Mind Medicine Inc’s stock first resistance to watch stands at $12.24. Second resistance stands at $12.72. The third major resistance level sits at $13.57. If the price goes on to break the first support level at $10.90, it is likely to go to the next support level at $10.05. The third support level lies at $9.56 if the price breaches the second support level.
Mind Medicine Inc (NASDAQ: MNMD) Key Stats
With a market capitalization of 1.16 billion, the company has a total of 98,509K Shares Outstanding. Currently, annual sales are 0 K while annual income is -108,680 K. The company’s previous quarter sales were 0 K while its latest quarter income was -67,270 K.
